Sfoglia per Autore
Mostrati risultati da 1 a 2 di 2
Short-term, intensive chemotherapy regimen is equally effective in Burkitt lymphoma (BL) and in the novel WHO 2008 entity “B-cell lymphoma intermediate between DLBCL and BL".
2011-01-01 Bonifacio, Massimiliano; Furlani, Lara; Zamo', Alberto; Corradi, Gabriele; Moretta, Francesca; Mosna, F; Carli, G; Chilosi, Marco; Todeschini, Giuseppe; Ambrosetti, Achille; Pizzolo, G.
Modified HyperCVAD and rituximab for the treatment of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma.
2013-01-01 Bonifacio, Massimiliano; Furlani, Lara; Zamo', Alberto; Corradi, Gabriele; Chilosi, Marco; Todeschini, Giuseppe; Pizzolo, G; Ambrosetti, Achille
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Short-term, intensive chemotherapy regimen is equally effective in Burkitt lymphoma (BL) and in the novel WHO 2008 entity “B-cell lymphoma intermediate between DLBCL and BL". | 1-gen-2011 | Bonifacio, Massimiliano; Furlani, Lara; Zamo', Alberto; Corradi, Gabriele; Moretta, Francesca; Mosna, F; Carli, G; Chilosi, Marco; Todeschini, Giuseppe; Ambrosetti, Achille; Pizzolo, G. | |
Modified HyperCVAD and rituximab for the treatment of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. | 1-gen-2013 | Bonifacio, Massimiliano; Furlani, Lara; Zamo', Alberto; Corradi, Gabriele; Chilosi, Marco; Todeschini, Giuseppe; Pizzolo, G; Ambrosetti, Achille |
Mostrati risultati da 1 a 2 di 2
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile